589 398

Cited 0 times in

Design and Synthesis of Fluoroquinophenoxazines That Interact with Human Telomeric G-Quadruplexes and Their Biological Effects

DC Field Value Language
dc.contributor.author라선영-
dc.date.accessioned2016-02-19T10:59:32Z-
dc.date.available2016-02-19T10:59:32Z-
dc.date.issued2001-
dc.identifier.issn1535-7163-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/142150-
dc.description.abstractIn this study we have identified a new structural motif for a ligand with G-quadruplex interaction that results in biological effects associated with G-quadruplex-interactive compounds. Fluoroquinolones have been reported to possess weak telomerase inhibitory activity in addition to their better known bacterial gyrase poisoning. Starting with a fluoroquinobenzoxazine, which has modest potency in a human topoisomerase II assay, we have designed a more potent inhibitor of telomerase that has lost its topoisomerase II poisoning activity. This fluoroquinophenoxazine (FQP) interacts with G-quadruplex structures to inhibit the progression of Taq polymerase in a G-quadruplex polymerase stop assay. In addition, we demonstrate by 1H NMR studies that this compound interacts with telomeric G-quadruplex structures by external stacking to the G-tetrad with both the unimolecular fold-over and the parallel G-quadruplex structures. A photocleavage assay confirms the FQP interaction site, which is located off center of the external tetrad but within the loop region. Molecular modeling using simulated annealing was performed on the FQP-parallel G-quadruplex complex to determine the optimum FQP orientation and key molecular interactions with the telomeric G-quadruplex structure. On the basis of the results of these studies, two additional FQP analogues were synthesized, which were designed to test the importance of these key interactions. These analogues were evaluated in the Taq polymerase stop assay for G-quadruplex interaction. The data from this study and the biological evaluation of these three FQPs, using cytotoxicity and a sea urchin embryo system, were in accord with the predicted more potent telomeric G-quadruplex interactions of the initial lead compound and one of the analogues. On the basis of these structural and biological studies, the design of more potent and selective telomeric G-quadruplex-interactive compounds can be envisaged.-
dc.description.statementOfResponsibilityopen-
dc.format.extent103~120-
dc.relation.isPartOfMOLECULAR CANCER THERAPEUTICS-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAnimals-
dc.subject.MESHAntineoplastic Agents/chemical synthesis*-
dc.subject.MESHAntineoplastic Agents/metabolism-
dc.subject.MESHAntineoplastic Agents/pharmacology-
dc.subject.MESHCell Division/drug effects-
dc.subject.MESHChromosomes/drug effects-
dc.subject.MESHChromosomes/genetics-
dc.subject.MESHDNA, Neoplasm/metabolism-
dc.subject.MESHDrug Design-
dc.subject.MESHEnzyme Inhibitors/chemical synthesis*-
dc.subject.MESHEnzyme Inhibitors/metabolism-
dc.subject.MESHEnzyme Inhibitors/pharmacology-
dc.subject.MESHFluoroquinolones/chemical synthesis*-
dc.subject.MESHFluoroquinolones/pharmacology-
dc.subject.MESHHumans-
dc.subject.MESHLight-
dc.subject.MESHMagnetic Resonance Spectroscopy-
dc.subject.MESHNucleic Acid Conformation/drug effects-
dc.subject.MESHSea Urchins/cytology-
dc.subject.MESHSea Urchins/embryology-
dc.subject.MESHSea Urchins/genetics-
dc.subject.MESHSubstrate Specificity-
dc.subject.MESHTelomerase/antagonists & inhibitors*-
dc.subject.MESHTelomere/metabolism-
dc.subject.MESHTopoisomerase II Inhibitors-
dc.subject.MESHTumor Cells, Cultured/drug effects-
dc.subject.MESHTumor Cells, Cultured/enzymology-
dc.titleDesign and Synthesis of Fluoroquinophenoxazines That Interact with Human Telomeric G-Quadruplexes and Their Biological Effects-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학)-
dc.contributor.googleauthorWenhu Duan-
dc.contributor.googleauthorAnupama Rangan-
dc.contributor.googleauthorHariprasad Vankayalapati-
dc.contributor.googleauthorMu-Yong Kim-
dc.contributor.googleauthorQingping Zeng-
dc.contributor.googleauthorDaekyu Sun-
dc.contributor.googleauthorHaiyong Han-
dc.contributor.googleauthorOleg Yu. Fedoroff-
dc.contributor.googleauthorDavid Nishioka-
dc.contributor.googleauthorSun Young Rha-
dc.contributor.googleauthorElzbieta Izbicka-
dc.contributor.googleauthorDaniel D. Von Hoff-
dc.contributor.googleauthorLaurence H. Hurley-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA01316-
dc.relation.journalcodeJ02254-
dc.identifier.eissn1538-8514-
dc.identifier.pmid12467228-
dc.contributor.alternativeNameRha, Sun Young-
dc.contributor.affiliatedAuthorRha, Sun Young-
dc.rights.accessRightsfree-
dc.citation.volume1-
dc.citation.number2-
dc.citation.startPage103-
dc.citation.endPage120-
dc.identifier.bibliographicCitationMOLECULAR CANCER THERAPEUTICS, Vol.1(2) : 103-120, 2001-
dc.identifier.rimsid31640-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.